Full Text Journal Articles by
Author Sook Hee Hong

Advertisement

Find full text journal articles






How to start niraparib in real-world Asian ovarian cancer patients?

Sook Hee Hong,

J Gynecol Oncol (Journal of gynecologic oncology)
[2021, 32(2):e36]

Cited: 0 times

View full text PDF listing >>



The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy

Seo Ree Kim, Sang hoon Chun, Jin-Hyoung Kang, Joo ri Kim, Sang-Yeob Kim, Jun young Seo, Chan Kwon Jung, Bo-Mi Gil, Jeong-Oh Kim, Yoon Ho Ko, In Sook Woo, Byoung Yong Shim, Sook-Hee Hong,

<h4>Background: </h4> Immune checkpoint blockades (ICBs) are characterized by a durable clinical response and better tolerability in patients with a variety of advanced solid tumors. However, we not infrequently encounter patients with hyperprogressive disease (HPD) exhibiting paradoxically accelerated tumor growth with poor clinical outcomes. This study aimed to investigate implications ... Read more >>

()
[, :]

Cited: 0 times

View full text PDF listing >>



Advertisement

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.

Seo Ree Kim, Sang Hoon Chun, Joo Ri Kim, Sang-Yeob Kim, Jun Young Seo, Chan Kwon Jung, Bo-Mi Gil, Jeong-Oh Kim, Yoon Ho Ko, In Sook Woo, Byoung Yong Shim, Sook-Hee Hong, Jin Hyoung Kang,

<h4>Background</h4>Immune checkpoint blockades (ICBs) are characterized by a durable clinical response and better tolerability in patients with a variety of advanced solid tumors. However, we not infrequently encounter patients with hyperprogressive disease (HPD) exhibiting paradoxically accelerated tumor growth with poor clinical outcomes. This study aimed to investigate implications of clinical ... Read more >>

BMC Cancer (BMC cancer)
[2021, 21(1):19]

Cited: 0 times

View full text PDF listing >>



Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.

Miso Kim, Bhumsuk Keam, Chan-Young Ock, Se Hyun Kim, Yu Jung Kim, Sun Min Lim, Jin-Soo Kim, Tae Min Kim, Sook-Hee Hong, Mi Sun Ahn, Seong Hoon Shin, Eun Joo Kang, Dong-Wan Kim, Sun-Wha Im, Jong-Il Kim, Jong Seok Lee, Joo-Hang Kim, Dae Seog Heo,

<h4>Background</h4>Pulmonary sarcomatoid carcinoma (PSC) is rare with a poor outcome and is resistant to conventional cytotoxic chemotherapy. The efficacy and safety of durvalumab and tremelimumab for treating recurrent or metastatic PSCs were assessed by a nonrandomized, open-label, phase II study.<h4>Methods</h4>A total of 18 patients with recurrent or metastatic PSC received ... Read more >>

Thorac Cancer (Thoracic cancer)
[2020, 11(12):3482-3489]

Cited: 0 times

View full text PDF listing >>



Prognostic effects of histology-based tumour microenvironment scores in resected distal bile duct cancer.

Hye W Hwang, Joo Y Kim, Seung E Lee, Yoo S Choi, Sook-Hee Hong, Tae J Lee, Mi K Kim, Eon S Park, Soon A Hong,

AIMS:Histology-based tumour microenvironment (TME) scores are useful in predicting the prognosis of gastrointestinal cancer. However, their prognostic roles in distal bile duct cancer (DBDC) have not been previously studied. This study aimed to evaluate the prognostic significance of the TME scores using the Klintrup-Mäkinen (KM) grade, tumour stroma percentage (TSP) ... Read more >>

Histopathology (Histopathology)
[2020, 77(3):402-412]

Cited: 0 times

View full text PDF listing >>



Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.

Sea-Won Lee, Yeon-Sil Kim, Soo Yoon Sung, Yoo-Kang Kwak, Young Nam Kang, Ji Sun Jang, Jin-Hyung Kang, Sook-Hee Hong, Seung Joon Kim, So Lyung Jung,

The role of radiosurgery has become further accentuated in the era of targeted agents (TA). Thus, the neurologic outcome of radiosurgery in brain metastasis (BM) of non-small cell lung cancer (NSCLC) was reviewed. We analyzed 135 patients with BM of NSCLC who were administered Cyberknife radiosurgery (CKRS) as either initial ... Read more >>

Clin Exp Metastasis (Clinical & experimental metastasis)
[2020, 37(2):353-363]

Cited: 0 times

View full text PDF listing >>



Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer.

Jeong-Oh Kim, Jung-Young Shin, Seo Ree Kim, Kab Soo Shin, Joori Kim, Min-Young Kim, Mi-Ran Lee, Yonggoo Kim, Myungshin Kim, Sook Hee Hong, Jin Hyoung Kang,

Epidermal growth factor receptor (<i>EGFR</i>) mutation testing is essential for individualized treatment using tyrosine kinase inhibitors. We evaluated two <i>EGFR</i> mutation tests, cobas v2 and PANAMutyper, for detection of <i>EGFR</i> activating mutations Ex19del, L858R, and T790M in tumor tissue and plasma from 244 non-small cell lung cancer (NSCLC) patients. The ... Read more >>

Cancers (Basel) (Cancers)
[2020, 12(4):]

Cited: 0 times

View full text PDF listing >>



Asian Society of Gynecologic Oncology International Workshop 2018.

Tae Wook Kong, Hee Sug Ryu, Seung Cheol Kim, Takayuki Enomoto, Jin Li, Kenneth H Kim, Seung Hyuk Shim, Peng Hui Wang, Suwanit Therasakvichya, Yusuke Kobayashi, Maria Lee, Tingyan Shi, Shin Wha Lee, Mikio Mikami, Satoru Nagase, Satoru Nagase, Myong Cheol Lim, Jianliu Wang, Sarikapan Wilailak, Sang Wun Kim, Sook Hee Hong, David Sp Tan, Masaki Mandai, Suk Joon Chang, Ruby Yun Ju Huang, Kimio Ushijima, Jung Yun Lee, Xiaojun Chen, Kazunori Ochiai, Taek Sang Lee, Bingyi Yang, Farhana Kalam, Qiaoying Lv, Mohd Faizal Ahmad, Muhammad Rizki Yaznil, Kanika Batra Modi, Manatsawee Manopunya, Dae Hoon Jeong, Arb Aroon Lertkhachonsuk, Hyun Hoon Chung, Hidemichi Watari, Seob Jeon,

The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop was an opportunity for Asian doctors to discuss the latest findings of gynecologic cancer, including cervical, ovarian, and endometrial cancers, ... Read more >>

J Gynecol Oncol (Journal of gynecologic oncology)
[2019, 30(2):e39]

Cited: 2 times

View full text PDF listing >>



Next generation sequencing can be helpful in histologic diagnosis: A case report of metastatic breast cancer mimicking atypical carcinoid tumor of lung.

In Hye Song, Sook-Hee Hong, Kyo Yeong Lee, Jun Kang, Sung Hak Lee, Jieun Lee, Ahwon Lee,

Development of molecular technology has led to the expansion of next generation sequencing (NGS) in area of diagnostic pathology. Here we present a case in which a lung tumor, which resembled an atypical carcinoid tumor, was revealed as metastatic breast cancer by next generation sequencing. A 50-year-old female, who had ... Read more >>

Pathol Res Pract (Pathology, research and practice)
[2020, 216(5):152835]

Cited: 0 times

View full text PDF listing >>



The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study.

Hyunho Kim, Ji Eun Lee, Sook Hee Hong, Myung Ah Lee, Jin Hyoung Kang, In-Ho Kim,

<h4>Background</h4>This study aimed to assess the effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing treatment with immune checkpoint inhibitors (ICIs).<h4>Methods</h4>The medical records of 234 patients treated with ICIs for any type of solid cancer between February 2012 and May 2018 at the Seoul St. Mary's ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1100]

Cited: 4 times

View full text PDF listing >>



Prognostic value of neutrophil-to-lymphocyte ratio in locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.

Eun Young Park, Yeon-Sil Kim, Kyu Hye Choi, Jin Ho Song, Hyo Chun Lee, Sook-Hee Hong, Jin-Hyoung Kang,

<h4>Purpose</h4>This study aimed to investigate neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors in patients with locally advanced non-small cell lung cancer (NSCLC) who received concurrent chemoradiotherapy (CCRT).<h4>Materials and methods</h4>We retrospectively analyzed 66 patients with locally advanced NSCLC treated with definitive CCRT. Among these patients, 95% received paclitaxel/carboplatin ... Read more >>

Radiat Oncol J (Radiation oncology journal)
[2019, 37(3):166-175]

Cited: 2 times

View full text PDF listing >>



Clinical Characteristics of Clear Cell Ovarian Cancer: A Retrospective Multicenter Experience of 308 Patients in South Korea.

Hee Yeon Lee, Ji Hyung Hong, Jae Ho Byun, Hee-Jun Kim, Sun Kyung Baek, Jin Young Kim, Ki Hyang Kim, Jina Yun, Jung A Kim, Kwonoh Park, Hyo Jin Lee, Jung Lim Lee, Young-Woong Won, Il Hwan Kim, Woo Kyun Bae, Kyong Hwa Park, Der-Sheng Sun, Suee Lee, Min-Young Lee, Guk Jin Lee, Sook Hee Hong, Yun Hwa Jung, Ho Jung An,

<h4>Purpose</h4>The purpose of this study was to evaluate clinical characteristics and treatment pattern of ovarian clear cell carcinoma (OCCC) in Korea and the role of adjuvant chemotherapy in early stage.<h4>Materials and methods</h4>Medical records of 308 cases of from 21 institutions were reviewed and data including age, performance status, endometriosis, thromboembolism, ... Read more >>

Cancer Res Treat (Cancer research and treatment)
[2020, 52(1):277-283]

Cited: 4 times

View full text PDF listing >>



Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling.

Sook-Hee Hong,

J Thorac Dis (Journal of thoracic disease)
[2019, 11(Suppl 3):S318-S321]

Cited: 0 times

View full text PDF listing >>



Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program.

Sook-Hee Hong, Ho Jung An, Kihyun Kim, Seung Sei Lee, Yun-Gyoo Lee, Young-Jin Yuh, I Cheon Park, Yee Soo Chae, Tae-Won Jang, Jin-Hyoung Kang,

<h4>Objectives</h4>Anti-angiogenic agents are reported to exert clinical activity on epidermal growth factor receptor (EGFR) mutant non-small-cell lung cancers. We evaluated the clinical outcomes of nintedanib and docetaxel in refractory NSCLC according to EGFR mutation status during the Korean nintedanib named patient program.<h4>Methods</h4>Docetaxel was administered either 75 or 37.5 mg/m2 on ... Read more >>

Oncology (Oncology)
[2019, 96(1):51-58]

Cited: 1 time

View full text PDF listing >>



Clinical Characteristics of False-Positive Lymph Node on Chest CT or PET-CT Confirmed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Lung Cancer.

Jongmin Lee, Young Kyoon Kim, Ye Young Seo, Eun Kyoung Choi, Dong Soo Lee, Yeon Sil Kim, Sook Hee Hong, Jin Hyoung Kang, Kyo Young Lee, Jae Kil Park, Sook Whan Sung, Hyun Bin Kim, Mi Sun Park, Hyeon Woo Yim, Seung Joon Kim,

<h4>Background</h4>Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a standard procedure to evaluate suspicious lymph node involvement of lung cancer because computed tomography (CT) and 18F-fluorodeoxyglucose positron emission tomography-CT (PET-CT) have limitations in their sensitivity and specificity. There are a number of benign causes of false positive lymph node such as ... Read more >>

Tuberc Respir Dis (Seoul) (Tuberculosis and respiratory diseases)
[2018, 81(4):339-346]

Cited: 2 times

View full text PDF listing >>



Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.

SooYoon Sung, Sea-Won Lee, Yoo-Kang Kwak, Jin Hyung Kang, Sook Hee Hong, Yeon-Sil Kim,

<h4>Introduction</h4>The efficacy of tyrosine kinase inhibitors (TKIs) with and without radiotherapy (RT) has not been determined in patients with brain metastases from epidermal growth factor receptor-mutant TKI naïve non-small cell lung cancer (NSCLC).<h4>Methods</h4>Between 2008 and 2016, 586 patients were diagnosed with NSCLC and treated with TKIs at a hospital in ... Read more >>

J Neurooncol (Journal of neuro-oncology)
[2018, 139(1):205-213]

Cited: 11 times

View full text PDF listing >>



Overexpression of YAP1 in EGFR mutant lung adenocarcinoma prior to tyrosine kinase inhibitor therapy is associated with poor survival.

Soon Auck Hong, Si-Hyong Jang, Mee-Hye Oh, Sung Joon Kim, Jin-Hyung Kang, Sook-Hee Hong,

EGFR tyrosine kinase inhibitor (EGFR TKI) is approved as first-line treatment for advanced-stage EGFR mutant lung adenocarcinoma (LADC). Yes-associated protein 1 (YAP1), a main effector of the Hippo pathway, is associated with adverse prognosis and disruption of EGFR TKI modulation of non-small cell lung cancer. In this study, we demonstrated ... Read more >>

Pathol Res Pract (Pathology, research and practice)
[2018, 214(3):335-342]

Cited: 3 times

View full text PDF listing >>



Changes in PD-L1 expression according to tumor infiltrating lymphocytes of acquired EGFR-TKI resistant EGFR-mutant non-small-cell lung cancer.

Tae-Jung Kim, Soon Auck Hong, Okran Kim, Seung Joon Kim, Ji-Hyun Yang, Eun Kyo Joung, Jin-Hyoung Kang, Sook-Hee Hong,

EGFR-mutant non-small cell lung cancer (NSCLC) that developed acquired resistance to EGFR-tyrosine kinase (TKI) are potential candidates for programmed death 1 (PD1) inhibitor.TPS≥1% for PD-L1 and low CD8 + TIL in post-TKI tumor showed a trend for a lower PFS of EGFR-TKIs (14.2 vs 9.9 months; P = 0.060) (cohort ... Read more >>

Oncotarget (Oncotarget)
[2017, 8(64):107630-107639]

Cited: 4 times

View full text PDF listing >>



Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression.

Maria Rusan, Kapsok Li, Yvonne Li, Camilla L Christensen, Brian J Abraham, Nicholas Kwiatkowski, Kevin A Buczkowski, Bruno Bockorny, Ting Chen, Shuai Li, Kevin Rhee, Haikuo Zhang, Wankun Chen, Hideki Terai, Tiffany Tavares, Alan L Leggett, Tianxia Li, Yichen Wang, Tinghu Zhang, Tae-Jung Kim, Sook-Hee Hong, Neermala Poudel-Neupane, Michael Silkes, Tenny Mudianto, Li Tan, Takeshi Shimamura, Matthew Meyerson, Adam J Bass, Hideo Watanabe, Nathanael S Gray, Richard A Young, Kwok-Kin Wong, Peter S Hammerman,

Acquired drug resistance is a major factor limiting the effectiveness of targeted cancer therapies. Targeting tumors with kinase inhibitors induces complex adaptive programs that promote the persistence of a fraction of the original cell population, facilitating the eventual outgrowth of inhibitor-resistant tumor clones. We show that the addition of a ... Read more >>

Cancer Discov (Cancer discovery)
[2018, 8(1):59-73]

Cited: 27 times

View full text PDF listing >>



The Use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists.

Mimi Kim, Hyo Jin Park, Hye Sook Min, Hyeong Ju Kwon, Chan Kwon Jung, Seoung Wan Chae, Hyun Ju Yoo, Yoo Duk Choi, Mi Ja Lee, Jeong Ja Kwak, Dong Eun Song, Dong Hoon Kim, Hye Kyung Lee, Ji Yeon Kim, Sook Hee Hong, Jang Sihn Sohn, Hyun Seung Lee, So Yeon Park, Soon Won Hong, Mi Kyung Shin,

<h4>Background</h4>The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) has standardized the reporting of thyroid cytology specimens. The objective of the current study was to evaluate the nationwide usage of TBSRTC and assess the malignancy rates in each category of TBSRTC in Korea.<h4>Methods</h4>Questionnaire surveys were used for data collection on the ... Read more >>

J Pathol Transl Med (Journal of pathology and translational medicine)
[2017, 51(4):410-417]

Cited: 6 times

View full text PDF listing >>



Clinical Significance of C-MET Overexpression and Epidermal Growth Factor Receptor Mutation in Platinum-Based Adjuvant Chemotherapy Outcome in Surgically Resected Lung Adenocarcinoma.

In-Ho Kim, In Hee Lee, Ji Eun Lee, Sook Hee Hong, Tae-Jung Kim, Kyo-Young Lee, Young Kyoon Kim, Seung Joon Kim, Sook Whan Sung, Jae Kil Park, Ie Ryung Yoo, Yeon Sil Kim, Jung-Oh Kim, Jin Hyoung Kang,

<h4>Purpose</h4>We retrospectively assessed the role of C-MET expression and epidermal growth factor receptor (EGFR) mutation on survival following platinum-based adjuvant chemotherapy. The impact of C-MET on survival was also investigated in relation to EGFR mutation status.<h4>Methods</h4>We enrolled 311 patients with resected lung adenocarcinoma (high-risk stage 1B-3A), and performed immunohistochemistry (IHC) ... Read more >>

Ann Surg Oncol (Annals of surgical oncology)
[2017, 24(3):770-777]

Cited: 5 times

View full text PDF listing >>



Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis.

Sook-Hee Hong, Yeon-Sil Kim, Ji Eun Lee, In-Ho Kim, Seung Joon Kim, Daehee Han, Ie Ryung Yoo, Yang-Guk Chung, Young-Hoon Kim, Kyo-Young Lee, Jin-Hyoung Kang,

<h4>Purpose</h4>The aim of this study was to analyze clinical characteristics of skeletal metastasis in epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) and treatment outcomes of continued EGFR tyrosine kinase inhibitor (TKI) therapy in patients presenting with skeletal metastasis progression.<h4>Materials and methods</h4>Of the 216 patients treated with ... Read more >>

Cancer Res Treat (Cancer research and treatment : official journal of Korean Cancer Association)
[2016, 48(3):1110-1119]

Cited: 6 times

View full text PDF listing >>



Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non-Small-Cell Lung Cancer.

In-Ho Kim, In Hee Lee, Ji Eun Lee, Sook Hee Hong, Tae-Jung Kim, Kyo-Young Lee, Young Kyoon Kim, Seung Joon Kim, Sook Whan Sung, Jae Kil Park, Ie Ryung Yoo, Yeon Sil Kim, Jung-Oh Kim, Jin Hyoung Kang,

<h4>Background</h4>Several studies have suggested risk factors for poor survival in stage IB non-small-cell lung cancer (NSCLC) patients. However, these factors are not definite indicators of adjuvant chemotherapy for stage IB cancer, and most of them can be used to consider adjuvant chemotherapy. We aimed to determine the clinicopathologic factors and ... Read more >>

Clin Lung Cancer (Clinical lung cancer)
[2016, 17(5):e31-e43]

Cited: 6 times

View full text PDF listing >>



A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer.

Keun-Wook Lee, Youngil Koh, Sung-Bae Kim, Sang-Won Shin, Jin-Hyoung Kang, Hong-Gyun Wu, Myung-Whun Sung, Bhumsuk Keam, Dong-Wan Kim, Tae Min Kim, Kwang Hyun Kim, Tack-Kyun Kwon, J Hun Hah, In-Ah Kim, Soon-Hyun Ahn, Dok Hyun Yoon, Sang-Wook Lee, Sang Yoon Kim, Soon Yuhl Nam, Kwang-Yoon Jung, Seung-Kuk Baek, Sook Hee Hong, Se-Hoon Lee, Dae Seog Heo,

<h4>Background</h4>We investigated the efficacy of cetuximab when added to induction chemotherapy followed by concurrent chemoradiotherapy (CCRT) in patients with locally advanced head and neck squamous cell carcinoma.<h4>Methods</h4>Patients were randomized to receive three cycles of docetaxel and cisplatin (TP regimen) with or without cetuximab (TP plus cetuximab [CTP] vs. TP) as ... Read more >>

Oncologist (The oncologist)
[2015, 20(10):1119-1120]

Cited: 11 times

View full text PDF listing >>



Clinical Correlation Between Tumor Maximal Standardized Uptake Value in Metabolic Imaging and Metastatic Tumor Characteristics in Advanced Non-small Cell Lung Cancer.

Dong Soo Lee, Seung Joon Kim, Hong Seok Jang, Ie Ryung Yoo, Kyung Ran Park, Sae Jung Na, Kyo Young Lee, Sook Hee Hong, Jin Hyoung Kang, Young Kyoon Kim, Yeon Sil Kim,

This study aimed to elucidate whether the maximal standardized uptake value (SUVmax) of primary tumors in metabolic imaging correlated with pathological or metastatic characteristics and whether it was prognostic in stage IV nonsmall cell lung cancer (NSCLC).We retrospectively reviewed the medical records of 412 eligible patients between June 2007 and ... Read more >>

Medicine (Baltimore) (Medicine)
[2015, 94(32):e1304]

Cited: 2 times

View full text PDF listing >>



Advertisement

Disclaimer
1.1696 s